MRNS - MARINUS PHARMACEUTICALS, INC.
IEX Last Trade
0.314
-0.023 -7.325%
Share volume: 1,000
Last Updated: Fri 27 Dec 2024 03:28:07 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.34
-0.02
-6.82%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-07 | 2023-03-09 | 2023-05-11 | 2023-08-10 | 2023-11-07 | 2024-03-05 | 2024-05-08 | |
| Total revenue | 1.790 M | 2.340 M | 7.162 M | 10.380 M | 6.081 M | 7.338 M | 7.190 M | 7.679 M | |
| Cost of revenue | 0.000 | 48.000 K | 1.461 M | 206.000 K | 386.000 K | 455.000 K | 887.000 K | 756.000 K | |
| Gross profit | 1.790 M | 2.292 M | 5.701 M | 10.174 M | 5.695 M | 6.883 M | 6.303 M | 6.923 M | |
| 28.04% | 148.73% | 78.46% | -44.02% | 20.86% | -8.43% | 9.84% | |||
| Operating expenses | 38.556 M | 32.391 M | 36.082 M | 43.137 M | 37.134 M | 38.529 M | 41.740 M | 42.744 M | |
| Selling general and admin | 17.061 M | 13.389 M | 14.658 M | 15.204 M | 15.722 M | 14.868 M | 15.358 M | 18.626 M | |
| Research and development | 21.495 M | 19.002 M | 21.424 M | 27.933 M | 21.412 M | 23.661 M | 26.382 M | 24.118 M | |
| Total expenses | 38.556 M | 32.439 M | 36.374 M | 43.343 M | 37.520 M | 38.984 M | 42.627 M | 43.500 M | |
| -15.87% | 12.13% | 19.16% | -13.43% | 3.90% | 9.34% | 2.05% | |||
| Operating income | -36.766 M | -30.099 M | -29.212 M | -32.963 M | -31.439 M | -31.646 M | -35.437 M | -35.821 M | |
| Ebit | -36.766 M | -30.099 M | -29.212 M | -32.963 M | -31.439 M | -31.646 M | -35.437 M | -35.821 M | |
| Pretax income | -39.433 M | 75.042 M | -32.675 M | -34.730 M | -33.472 M | -32.972 M | -41.769 M | -38.669 M | |
| -290.30% | -143.54% | 6.29% | -3.62% | -1.49% | 26.68% | -7.42% | |||
| Income tax | 0.000 | 1.752 M | 1.637 M | 0.000 | -1.538 M | 0.000 | 0.000 | 0.000 | |
| Net income basic | -39.433 M | 71.634 M | -32.656 M | -34.730 M | -31.934 M | -32.972 M | -41.769 M | -38.669 M | |
| 281.66% | -145.59% | -6.35% | 8.05% | -3.25% | -26.68% | 7.42% | |||
| Net income | -39.433 M | 71.634 M | -32.656 M | -34.730 M | -31.934 M | -32.972 M | -41.769 M | -38.669 M | |
| 281.66% | -145.59% | -6.35% | 8.05% | -3.25% | -26.68% | 7.42% |